首页>
外国专利>
Agent identification methods for the treatment of diabetes
Agent identification methods for the treatment of diabetes
展开▼
机译:糖尿病的病原鉴定方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of the human "MAP kinase interacting kinases" Mnk2a or Mnk2b in methods for identification of pharmaceutically usefull agents, in particular agents useful for the treatment of type II diabetes. The invention also relates to methods of treating or preventing medical conditions relating to insulin resistance by modulating the expression or activity of Mnk2a or Mnk2b.
展开▼